Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Falk

Showing results (471-480 of 537) with videos related to

Pageof 54
Sort By:
Blood|October 1, 1996
Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patientsR L Comenzo, E Vosburgh, R W Simms, et al.
Breast Cancer Research and Treatment|March 31, 2021
Congruence and trajectories of device-measured and self-reported physical activity during therapy for early breast cancerH Helbrich, M Braun, C Hanusch, et al.
The New England Journal of Medicine|January 1, 2015
The amyloidogenic V122I transthyretin variant in elderly black AmericansC Cristina Quarta, Joel N Buxbaum, Amil M Shah, et al.
Blood|June 15, 1992
Expression of the APO-1 antigen in Burkitt lymphoma cell lines correlates with a shift towards a lymphoblastoid phenotypeM H Falk, B C Trauth, K M Debatin, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|September 12, 2020
Inter-observer reproducibility and intra-observer repeatability in <sup>99m</sup>Tc-pyrophosphate scan interpretation for diagnosis of transthyretin cardiac amyloidosisVasvi Singh, Sarah Cuddy, Marie F Kijewski, et al.
Archives of Environmental Contamination and Toxicology|March 1, 1988
Correlation between serum and adipose tissue levels of 2,3,7,8-tetrachlorodibenzo-p-dioxin in 50 persons from MissouriD G Patterson, L L Needham, J L Pirkle, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|April 5, 2026
Assessment of Cardiac Involvement in Rare Forms of Amyloidosis Using PET/CT with <sup>124</sup>I-Evuzamitide (<sup>124</sup>I-p5+14, AT-01)Olivier F Clerc, Ardel J Romero Pabón, Sarah A M Cuddy, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 10, 2006
Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosisHarun Akar, David C Seldin, Barbarajean Magnani, et al.
Blood|May 25, 2004
Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantationDavid C Seldin, Jennifer J Anderson, Vaishali Sanchorawala, et al.
JAMA Cardiology|May 22, 2023
Age Dependency of Cardiovascular Outcomes With the Amyloidogenic pV142I Transthyretin Variant Among Black Individuals in the USSenthil Selvaraj, Brian L Claggett, C Cristina Quarta, et al.
Pageof 54

Showing results (471-480 of 537) with videos related to

Sort By:
Pageof 54
Blood|October 1, 1996
Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patientsR L Comenzo, E Vosburgh, R W Simms, et al.
Breast Cancer Research and Treatment|March 31, 2021
Congruence and trajectories of device-measured and self-reported physical activity during therapy for early breast cancerH Helbrich, M Braun, C Hanusch, et al.
The New England Journal of Medicine|January 1, 2015
The amyloidogenic V122I transthyretin variant in elderly black AmericansC Cristina Quarta, Joel N Buxbaum, Amil M Shah, et al.
Blood|June 15, 1992
Expression of the APO-1 antigen in Burkitt lymphoma cell lines correlates with a shift towards a lymphoblastoid phenotypeM H Falk, B C Trauth, K M Debatin, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|September 12, 2020
Inter-observer reproducibility and intra-observer repeatability in <sup>99m</sup>Tc-pyrophosphate scan interpretation for diagnosis of transthyretin cardiac amyloidosisVasvi Singh, Sarah Cuddy, Marie F Kijewski, et al.
Archives of Environmental Contamination and Toxicology|March 1, 1988
Correlation between serum and adipose tissue levels of 2,3,7,8-tetrachlorodibenzo-p-dioxin in 50 persons from MissouriD G Patterson, L L Needham, J L Pirkle, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|April 5, 2026
Assessment of Cardiac Involvement in Rare Forms of Amyloidosis Using PET/CT with <sup>124</sup>I-Evuzamitide (<sup>124</sup>I-p5+14, AT-01)Olivier F Clerc, Ardel J Romero Pabón, Sarah A M Cuddy, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 10, 2006
Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosisHarun Akar, David C Seldin, Barbarajean Magnani, et al.
Blood|May 25, 2004
Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantationDavid C Seldin, Jennifer J Anderson, Vaishali Sanchorawala, et al.
JAMA Cardiology|May 22, 2023
Age Dependency of Cardiovascular Outcomes With the Amyloidogenic pV142I Transthyretin Variant Among Black Individuals in the USSenthil Selvaraj, Brian L Claggett, C Cristina Quarta, et al.
Pageof 54